Dentsply Sirona price target raised to $21 from $20 at Barrington

Barrington analyst Michael Petusky raised the firm’s price target on Dentsply Sirona (XRAY) to $21 from $20 and keeps an Outperform rating on the shares. While stating that “one quarter of beating very muted expectations does not a turnaround make,” the firm believes this quarter may suggest the start of a stabilization of this business and although it remains cautious, it believes that “at this valuation level, the risk/reward continues to favor investment.”